Concepedia

Author

Daiki Ogawara

Nagasaki University

Also Known As

D. Ogawara, Daiki Ogawara, Ogawara, D., Takeshi Kitazaki

42

Publications

244

Citations

9

H-Index

17

Concepts

All Affiliations

Nagasaki UniversitySasebo City General HospitalNagasaki University Hospital
DO

About

Daiki Ogawara is an author at Nagasaki University specializing in oncology, medicine, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

118

2

Pathology

4

4

99

3

Health Sciences

2

2

61

4

Pharmacology

2

2

33

5

Immunology

1

1

31

Daiki Ogawara

×

9

Publications

193

Citations

9

H-Index

YearCitations

Remarkable response of nivolumab‐refractory lung cancer to salvage chemotherapy

Daiki Ogawara, Hiroshi Soda, Keisuke Iwasaki,

Thoracic Cancer

2017

38

Dynamics of blood neutrophil‐related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non‐small cell lung cancer: A hypothesis‐generating study

Hiroshi Soda, Daiki Ogawara, Yuichi Fukuda,

Thoracic Cancer

2018

31

Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)

Minoru Fukuda, Takeshi Kitazaki, Daiki Ogawara,

Lung Cancer

2019

30

Alert Regarding Cisplatin-induced Severe Adverse Events in Cancer Patients with Xeroderma Pigmentosum

Makoto Sumiyoshi, Hiroshi Soda, Noriaki Sadanaga,

Internal Medicine

2017

24

Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4

Daiki Ogawara, Minoru Fukuda, Shiro Ueno,

Supportive Care in Cancer

2015

19

Pulmonary pleomorphic carcinoma with few PD‐1‐positive immune cells and regulatory T cells that showed a complete response to nivolumab

Kazuaki Okamura, Yuichi Fukuda, Hiroshi Soda,

Thoracic Cancer

2017

16

Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations

Kosuke Mizoguchi, Yoichi Nakamura, Kazumi Sano,

Cancer Chemotherapy and Pharmacology

2016

14

Successful treatment with nivolumab for lung cancer with low expression of PD‐L1 and prominent tumor‐infiltrating B cells and immunoglobulin G

Takayuki Suyama, Yuichi Fukuda, Hiroshi Soda,

Thoracic Cancer

2018

11

Nivolumab infusion reaction manifesting as plantar erythema and pulmonary infiltrate in a lung cancer patient

Daiki Ogawara, Hiroshi Soda, Susumu Ikehara,

Thoracic Cancer

2017

10

Page 1